跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
莫比可 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Meloxicam Injection
Approved
化学药品
Meloxicam Injection
BOEHRINGER INGELHEIM FRANCE
🇨🇳 National Medical Products Administration
Approval Date
Jul 21, 2020
Approval ID
81u8kAcxzRO
Company
BOEHRINGER INGELHEIM FRANCE
Type
化学药品
Approval Details
Approval Id
81u8kAcxzRO
Approval Number
国药准字HJ20150536
Generic Name
美洛昔康注射液
Generic Name En
Meloxicam Injection
Trade Name
莫比可
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.5ml:15mg
Reg Date
2020-07-21
Expired Date
2025-07-20
Company Name
BOEHRINGER INGELHEIM FRANCE
Company Address
14 rue Jean-Antoine de Baif 75013 Paris, France
Production Company Name
boehringer ingelheim espana, s.a.
Production Company Address
Prat de la Riba,50,08174 Sant Cugat del Valles (Barcelona), Spain
Company Detail Path
/organization/boehringer-ingelheim-france
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 21, 2020
Approval ID
81u8kAcxzRO
Type
化学药品
Back to NMPA Approvals